Abeona Therapeutics Inc
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt dise… Read more
Abeona Therapeutics Inc (ABEO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.124x
Based on the latest financial reports, Abeona Therapeutics Inc (ABEO) has a cash flow conversion efficiency ratio of -0.124x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-21.19 Million) by net assets ($171.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Abeona Therapeutics Inc - Cash Flow Conversion Efficiency Trend (1995–2024)
This chart illustrates how Abeona Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Abeona Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abeona Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
-3.332x |
|
Nanchang Mineral Systems Co. Ltd. A
SHE:001360
|
N/A |
|
Ahluwalia Contracts (India) Limited
NSE:AHLUCONT
|
0.129x |
|
Elematec Corporation
PINK:EEAEF
|
0.061x |
|
Vastned Retail NV
AS:VASTN
|
0.030x |
|
Shenzhen Water Planning & Design Institute Co. Ltd.
SHE:301038
|
N/A |
|
NUIX Ltd
AU:NXL
|
0.069x |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
|
0.010x |
Annual Cash Flow Conversion Efficiency for Abeona Therapeutics Inc (1995–2024)
The table below shows the annual cash flow conversion efficiency of Abeona Therapeutics Inc from 1995 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $44.03 Million | $-56.02 Million | -1.272x | +49.04% |
| 2023-12-31 | $14.83 Million | $-37.01 Million | -2.496x | -53.63% |
| 2022-12-31 | $26.76 Million | $-43.48 Million | -1.625x | -4.84% |
| 2021-12-31 | $42.37 Million | $-65.67 Million | -1.550x | -353.87% |
| 2020-12-31 | $102.55 Million | $-35.02 Million | -0.341x | +3.01% |
| 2019-12-31 | $178.43 Million | $-62.82 Million | -0.352x | -20.67% |
| 2018-12-31 | $134.04 Million | $-39.11 Million | -0.292x | -116.40% |
| 2017-12-31 | $170.10 Million | $-22.93 Million | -0.135x | -2.67% |
| 2016-12-31 | $99.10 Million | $-13.01 Million | -0.131x | +14.67% |
| 2015-12-31 | $67.72 Million | $-10.42 Million | -0.154x | +53.99% |
| 2014-12-31 | $4.82 Million | $-1.61 Million | -0.335x | -494272.28% |
| 2013-12-31 | $-14.78 Million | $1.00K | 0.000x | -100.03% |
| 2012-12-31 | $-17.08 Million | $-3.96 Million | 0.232x | -46.41% |
| 2011-12-31 | $-17.61 Million | $-7.61 Million | 0.432x | +31.01% |
| 2010-12-31 | $-20.80 Million | $-6.86 Million | 0.330x | +296.06% |
| 2009-12-31 | $-26.99 Million | $-2.25 Million | 0.083x | -85.80% |
| 2008-12-31 | $-11.19 Million | $-6.56 Million | 0.586x | -91.75% |
| 2007-12-31 | $681.00K | $4.84 Million | 7.112x | +3491.03% |
| 2006-12-31 | $-9.89 Million | $-1.96 Million | 0.198x | -88.51% |
| 2005-12-31 | $-4.24 Million | $-7.30 Million | 1.723x | +26.45% |
| 2004-12-31 | $-6.66 Million | $-9.08 Million | 1.363x | +24.75% |
| 2003-12-31 | $-5.83 Million | $-6.36 Million | 1.092x | +106.21% |
| 2002-12-31 | $489.00K | $-8.60 Million | -17.577x | -2926.58% |
| 2001-12-31 | $9.08 Million | $-5.27 Million | -0.581x | -101.19% |
| 2000-12-31 | $15.00 Million | $-4.33 Million | -0.289x | +67.98% |
| 1999-12-31 | $3.60 Million | $-3.25 Million | -0.901x | +49.30% |
| 1998-12-31 | $1.80 Million | $-3.20 Million | -1.778x | +70.65% |
| 1997-12-31 | $599.00K | $-3.63 Million | -6.057x | -821.68% |
| 1996-12-31 | $4.06 Million | $-2.67 Million | -0.657x | -268.38% |
| 1995-12-31 | $1.69 Million | $658.00K | 0.390x | -- |